Phase 2 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old (inclusive) at the time of signing the consent form
- You have been diagnosed with plaque psoriasis for at least 6 months before your screening visit
- At least 10% of your body surface area is affected by psoriasis at the time of screening and when the study begins
- Your psoriasis is rated as moderately severe or worse based on two standard medical scoring tools (PASI score of 12 or higher, and a physician's overall rating of 3 or higher) at screening and when the study begins
Who may not be able to join:
- You have a type of psoriasis other than plaque psoriasis, such as erythrodermic, guttate, inverse, pustular, or drug-induced psoriasis
- You have uncontrolled high blood pressure, meaning your blood pressure readings are consistently 160/100 mm Hg or above (confirm with trial site)
- You have been diagnosed with severe heart failure classified as Class III or IV by standard heart failure guidelines (confirm with trial site)
- You have a history of long-term, recurring bacterial infections, such as chronic kidney infections, chronic lung infections, or chronic bone infections
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 137 8709 7676
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving Psoriasis Area Severity Index (PASI) 75 Score at Week 16
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.